​

Progyny (PGNY) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PGNY Stock Forecast

Progyny (PGNY) stock forecast, based on 20 Wall Street analysts, predicts a 12-month average price target of $34.43, with a high of $40.00 and a low of $28.00. This represents a 11.93% increase from the last price of $30.76.

$15 $20 $25 $30 $35 $40 High: $40 Avg: $34.43 Low: $28 Last Closed Price: $30.76

PGNY Stock Rating

Progyny stock's rating consensus is Buy, based on 20 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (70.00%), 6 Hold (30.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 20 0 6 14 Strong Sell Sell Hold Buy Strong Buy

PGNY Price Target Upside V Benchmarks

TypeNameUpside
StockProgyny11.93%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 19.01%

Price Target Trends

1M3M12M
# Anlaysts5715
Avg Price Target$36.60$34.29$32.40
Last Closing Price$30.76$30.76$30.76
Upside/Downside18.99%11.48%5.33%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26281--11
Jun, 26281--11
May, 26272--11
Apr, 26272--11
Mar, 26272--11
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 28, 2026Peter WarendorfBarclays$34.00$31.597.63%10.53%
Jul 24, 2026BTIG$40.00$30.7030.29%30.04%
Jul 22, 2026Michael ChernyLeerink Partners$38.00$32.2417.87%23.54%
Jul 21, 2026Canaccord Genuity$36.00$31.7713.31%17.04%
Jul 13, 2026KeyBanc$35.00$30.6514.19%13.78%
May 19, 2026Canaccord Genuity$30.00$24.0524.74%-2.47%
May 15, 2026Barclays$27.00$23.2516.13%-12.22%
Mar 06, 2026Brian TanquilutJefferies$30.00$17.7968.63%-2.47%
Mar 02, 2026Jailendra SinghTruist Financial$28.00$17.6958.28%-8.97%
Jan 21, 2026J.P. Morgan$35.00$25.2838.45%13.78%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 24, 2026BTIGBuyBuyhold
Jul 13, 2026KeyBancOverweightOverweighthold
May 15, 2026BarclaysOverweightOverweighthold
May 11, 2026CitigroupOutperformOutperformhold
Mar 06, 2026JefferiesBuyBuyhold
Jan 21, 2026BTIGBuyBuyhold
Jan 20, 2026CitigroupOutperformupgrade
Jan 12, 2026Bank of America SecuritiesBuyBuyhold
Jan 08, 2026KeyBancOverweightOverweighthold
Dec 08, 2025BarclaysOverweightinitialise

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.74$0.33$0.65$0.59$0.68---
Avg Forecast$0.54$0.28$0.59$0.54$0.60$0.90$1.26$1.41
High Forecast$0.57$0.29$0.61$0.55$0.68$1.27$1.44$1.45
Low Forecast$0.51$0.27$0.58$0.53$0.52$0.63$1.11$1.36
Surprise %37.04%17.86%10.17%9.26%13.33%---

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$500.62M$786.91M$1.09B$1.17B$1.29B---
Avg Forecast$507.85M$784.27M$1.09B$1.14B$1.16B$1.29B$1.46B$1.65B
High Forecast$533.20M$799.56M$1.10B$1.17B$1.18B$1.30B$1.46B$1.69B
Low Forecast$485.64M$764.43M$1.06B$1.13B$1.14B$1.29B$1.46B$1.61B
Surprise %-1.42%0.34%-0.38%1.98%11.20%---

Net Income Forecast

$0 $30M $60M $90M $120M $150M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$65.77M$30.36M$62.04M$54.34M$58.52M---
Avg Forecast$54.03M$108.97M$62.04M$54.38M$60.07M$77.16M$128.36M$141.44M
High Forecast$57.53M$130.76M$74.44M$55.77M$68.28M$128.28M$144.97M$145.51M
Low Forecast$50.96M$87.17M$49.63M$53.00M$51.86M$63.12M$111.75M$136.60M
Surprise %21.73%-72.14%--0.08%-2.58%---

PGNY Forecast FAQ

Is Progyny stock a buy?

Progyny stock has a consensus rating of Buy, based on 20 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 6 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Progyny is a favorable investment for most analysts.

What is Progyny's price target?

Progyny's price target, set by 20 Wall Street analysts, averages $34.43 over the next 12 months. The price target range spans from $28 at the low end to $40 at the high end, suggesting a potential 11.93% change from the previous closing price of $30.76.

How does Progyny stock forecast compare to its benchmarks?

Progyny's stock forecast shows a 11.93% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the healthcare information services stocks industry (19.01%).

What is the breakdown of analyst ratings for Progyny over the past three months?

  • July 2026: 18.18% Strong Buy, 72.73% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 18.18% Strong Buy, 72.73% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 18.18% Strong Buy, 63.64% Buy, 18.18% Hold, 0% Sell, 0% Strong Sell.

What is Progyny’s EPS forecast?

Progyny's average annual EPS forecast for its fiscal year ending in December 2026 is $0.9, marking a 32.35% increase from the reported $0.68 in 2025. Estimates for the following years are $1.26 in 2027, and $1.41 in 2028.

What is Progyny’s revenue forecast?

Progyny's average annual revenue forecast for its fiscal year ending in December 2026 is $1.29B, reflecting a 0.33% increase from the reported $1.29B in 2025. The forecast for 2027 is $1.46B, and $1.65B for 2028.

What is Progyny’s net income forecast?

Progyny's net income forecast for the fiscal year ending in December 2026 stands at $77.16M, representing an 31.85% increase from the reported $58.52M in 2025. Projections indicate $128.36M in 2027, and $141.44M in 2028.